Home / Products / Biosynthesis Chemicals / Apoptosis Inhibitors / Caspase & Granzyme B Inhibitors /

Caspase & Granzyme B Inhibitors

Our Caspase & Granzyme B Inhibitors are essential tools in the field of apoptosis research Caspases and granzyme B are key enzymes involved in programmed cell death and our inhibitors are specifically designed to block their activity By inhibiting these enzymes our product allows researchers to study the intricate mechanisms of apoptosis and its role in various biological processes including development immune response and cancer With our high-quality inhibitors scientists can gain valuable insights into the regulation of cell death and potentially uncover new therapeutic targets for disease intervention

Get A Quote
Products Application Supporting Data Resources Related Products


Catalog Number Chemical Name CAS # Price
BC-0867 Caspase-Family Inhibitor Z-VAD-FMK 187389-52-2 Online Inquiry
BC-0869 FMK Negative Control 197855-65-5 Online Inquiry


The Caspase & Granzyme B inhibitors find applications in various fields particularly in the field of biomedical research and drug development In research these inhibitors are invaluable tools for studying the mechanisms of cell death as they allow scientists to selectively block the action of caspases and granzyme B two key enzymes involved in apoptosis and immune cell-mediated cytotoxicity respectively By inhibiting these enzymes researchers can gain a deeper understanding of the processes underlying cell death and develop potential therapeutic strategies

In the realm of drug development Caspase & Granzyme B inhibitors are being explored as potential treatments for various diseases and conditions For example caspase inhibitors have shown promise in mitigating the damage caused by neurodegenerative disorders such as Alzheimer's and Parkinson's disease Similarly Granzyme B inhibitors hold potential for improving outcomes in immune-mediated diseases such as autoimmune disorders and organ transplant rejection

By targeting specific enzymes involved in disease pathways Caspase & Granzyme B inhibitors offer a targeted approach to tackling complex biological processes and hold promise for the development of novel therapeutic interventions

Supporting Data


Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.


There is no product in your cart.